PROTON PUMP INHIBITORS-GENERAL INFORMATION Flashcards
What is the mechanism of action of PPIs
,PPIs inhibit the hydrogen potassium ATPase (proton pump) in the gastric parietal cells, which blocks the final step in gastric acid secretion.
How do PPIs relieve heartburn and dyspepsia
,PPIs (Proton Pump Inhibitors) relieve heartburn and dyspepsia by decreasing gastric acid secretion. They irreversibly block the hydrogen potassium ATPase (proton pump), providing a more potent and prolonged antisecretory effect compared to H2RAs.
How does the onset of symptomatic relief differ between H2RAs and PPIs
,The onset of symptomatic relief after an oral dose of PPIs may occur in 1-3 hours, but complete relief may take 1-4 days. In contrast, H2RAs have a faster onset of action but a shorter duration of effect compared to PPIs.
What is the difference in bioavailability of PPIs with continued daily dosing
,The bioavailability of PPIs is increased with continued daily dosing. However, if taken after a meal, the bioavailability is reduced compared to fasting.
What is the specific target of PPIs in gastric acid secretion
,PPIs specifically inhibit the hydrogen potassium ATPase (proton pump) in the gastric parietal cells, which is responsible for the final step in gastric acid secretion.
What is the indication for nonprescription PPIs
,Nonprescription PPIs are indicated for the treatment of frequent heartburn, defined as the occurrence of symptoms 2 or more days a week.
Are nonprescription PPIs intended for immediate relief of occasional or acute episodes of heartburn
,No, nonprescription PPIs are not intended for immediate relief of occasional or acute episodes of heartburn and dyspepsia.
When is the most effective time to take PPIs
,PPIs are most effective when taken 30–60 minutes before a meal, preferably before breakfast, as they inhibit only those proton pumps that are actively secreting acid.
How long should self-treatment with nonprescription PPIs be limited to
,Self-treatment with nonprescription PPIs should be limited to 14 days.
What is the recommended frequency of use for nonprescription PPIs
,The recommended frequency of use for nonprescription PPIs should be no greater than once every 4 months.
When is a medical evaluation recommended during PPI treatment
,A medical evaluation is recommended if heartburn continues during treatment with a nonprescription PPI, persists for more than 2 weeks, or recurs within 4 months.
What are some uncommon adverse effects of short-term PPI use
,Some uncommon adverse effects of short-term PPI use may include headache, abdominal pain, diarrhea, constipation, or flatulence.
What are the rare cases of adverse effects reported with PPI therapy
,Rare cases of adverse effects reported with PPI therapy include acute interstitial nephritis and subacute cutaneous lupus erythematosus, occurring within weeks or months of initiation of PPI therapy.
What is the potential risk associated with PPI use and traveler’s diarrhea
,PPI use may increase the risk of infectious traveler’s diarrhea by decreasing gastric acid and potentially altering gut flora. Travelers to high-risk areas should discuss the risks and benefits of continuing PPI use with a knowledgeable health care provider before the planned trip.
What is the association between PPI use and Clostridioides difficile (C. difficile) infection
,PPI use has been linked to an increased risk of C. difficile infection, although the overall quality of evidence for this potential adverse effect is low. Patients with a history of C. difficile infection and/or concomitant treatment with broad-spectrum antibiotics should exercise caution when using PPIs.